Identifying Research Gaps in the Diagnosis and Treatment of Hypertension: Evidence from a Guideline Update

Nizal Sarrafzadegan, Shahla Shahidi, Fahimeh B. Kholenjani

Abstract


Background: The development of clinical practice guidelines presents a unique opportunity to identify research gaps systematically. This study aimed to uncover such gaps in the hypertension field while updating the Iranian hypertension guideline.

Materials and Methods: This study was conducted as part of the systematic review component of the 2021 Iranian hypertension guideline update. An extensive search of electronic databases was performed to identify evidence relevant to PICO (Population, Interventions, Comparisons, Outcomes) questions. Any topic without evidence with high certainty of effect was considered a knowledge gap.

Results: A total of 227 studies were reviewed and appraised. Nine topics, such as non‑pharmacological treatment, treatment thresholds, visit and follow‑up intervals, laboratory tests, drug immunotherapy, adherence to treatment, complementary medicine, telehealth, COVID‑19 were identified as research gaps.

Conclusions: The identified research gaps can be examined and prioritized by policymakers in the research field, and actions can be taken to plan for addressing them.


Keywords


Evidence gaps, hypertension, practice guideline

Full Text:

PDF

References


Robinson KA, Saldanha IJ, McKoy NA. Identification of research gaps from evidence based guidelines: A pilot study in cystic fibrosis. Int J Technol Assess Health Care 2011;27:247 52.

Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens (Greenwich) 2008;10:644 6.

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2018;71:e127 248.

World Health Organization. WHO Handbook for Guideline Development. World Health Organization; 2014.

Kredo T, Bernhardsson S, Machingaidze S, Young T, Louw Q, Ochodo E, et al. Guide to clinical practice guidelines: The current state of play. Int J Qual Health Care 2016;28:122 8.

Burgers JS, Wittenberg J, Keuken DG, Dekker F, Hohmann FP, Leereveld D, et al. Development of a research agenda for general practice based on knowledge gaps identified in Dutch guidelines and input from 48 stakeholders. Eur J Gen Pract 2019;25:19 24.

Hempel S, Gore K, Belsher B. Identifying research gaps and prioritizing psychological health evidence synthesis needs. Med Care 2019;57 Suppl 10 Suppl 3 (10 Suppl 3):S259 64.

Isfahan Cardiovascular Research Institute. Updating Iranian Clinical Practice Guideline of Diagnosis and Treatment of Hypertension. Available from: https://icrc.mui.ac.ir/fa/guidelines. [Last accessed on 2025 Jun 09].

Bagherikholenjani F, Shahidi S, Khosravi A, Mansouri A, Ashoorion V, Sarrafzadegan N, et al. Update of the clinical guideline for hypertension diagnosis and treatment in Iran. Clin Hypertens 2024;30:13.

Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. The GRADE Working Group; 2013. Available from: guidelinedevelopment org/handbook. 2018. [Last accessed on 2025 Jun 09].

Sutton L, Karan A, Mahal A. Evidence for cost effectiveness of lifestyle primary preventions for cardiovascular disease in


Refbacks

  • There are currently no refbacks.